Article Text

Download PDFPDF
Refractory sarcoidosis-like systemic granulomatosis responding to ruxolitinib
  1. Michael Levraut1,
  2. Nihal Martis1,
  3. Philippe Viau2,
  4. Felipe Suarez3,
  5. Viviane Queyrel1
  1. 1 Internal Medicine, Universite Cote d'Azur, Nice, France
  2. 2 Nuclear Medicine, Universite Cote d'Azur, Nice, France
  3. 3 Pediatric Immuno-Hematology, APHP, Paris, France
  1. Correspondence to Dr Michael Levraut, Internal Medicine, Universite Cote d'Azur, Nice 06100, France; michael.levraut{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In 2012, a 51-year-old woman presented with a 2-year history of painful hepatomegaly, chronic asthenia and recurrent fevers. Her medical history comprised augmentation mammoplasty 6 years prior to the onset of her symptoms and she received fenofibrate as a treatment for dyslipidaemia. Physical examination found an increased liver span and splenomegaly, cervical lymphadenopathy, and peritoneal and pleural effusion outbreaks. There was neither rash nor joint pain. Plasma inflammatory markers were constantly raised with C reactive protein (CRP) levels of 80–100 mg/L, increasing when fever and effusions occurred. Subsequently, in the course of the disease, biochemical analysis found hypercalcaemia peaking at 3.81 mmol/L with hypercalciuria. The blood cells count, serum angiotensin conversion enzyme, parathormone (PTH), PTH-rp and plasma protein electrophoresis were constantly unremarkable. Fludeoxyglucose F18 positron-emission tomography (FDG-PET) showed heterogeneous hypermetabolism of the liver, spleen, entire bone frame and several mediastinal, thoracic and abdominal lymph nodes (figure 1). Repetitive pleural …

View Full Text


  • Handling editor Josef S Smolen

  • Contributors All named authors took a place in the drafting of the manuscript, the final approval of the version published and agree to be accountable for all aspects of the work.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.